The stock's fall snapped a seven-day winning streak.

The new campaign stars former NFL quarterback Alex Smith, whose leg injury during a 2018 game led to a case of ...

"It is not some Disney story of just triumph and resilience, it was really hard," Smith tells PEOPLE about his recovery ...

S&P Global reported quarterly adjusted earnings per share of $4.37 on Tuesday, beating the analyst consensus estimate of ...

MRNA reports mixed Q1 results. The company reiterates 2025 sales guidance but announces a cost-cutting initiative to reduce ...

NFL fans might remember Smith's awful injury and incredible comeback. The experience taught him about the importance of a pain game plan.

Vertex Pharmaceuticals outpaced the broader market, closing up 1.19% while major indices mostly tiptoed forward. Over the ...

Some may know him as the fearless shot-blocker, some may know him as the NBA champion, others might know him as Olympic gold ...

Biogen beat Q1 earnings and revenue estimates, raised rare disease drug sales, and cut its 2025 EPS guidance due to a $165 million collaboration payment.

Earlier this year, Vertex Pharma and CRISPR Therapeutics' Casgevy (exagamglogene autotemcel) for sickle cell disease and beta thalassaemia became the first-ever CRISPR-based therapy to be approved ...

The Board of Directors of Vertex Securities Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2025 - Q4FY25, Q4FY2025, FY2024-25, ...

Palo Alto Networks (NASDAQ: PANW) is a leader in the cybersecurity industry, with a market value of $111 billion. Over the past decade, the stock has delivered annual gains of over 21%, and over 40% ...